Ozan Cemal Icacan (Ozan Cemal Içaçan)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Cross Sectional

Rheumatoid Arthritis Patients

Extracorporeal Membrane Oxygenation

Top Venues

International journal of rheumatic diseases

Rheumatology international

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hale Gulcin Yildirim Dogan, Fatih Yildirim, Ozan Cemal Icacan, Melek Yalcin Mutlu, Selda Çelik, Cemal Beş
Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides: A single center experience from Turkey. International journal of rheumatic diseases (2023)
Gizem Kaynar Özçelik, Ozan Cemal Icacan, Melek Yalcin Mutlu, Fatih Yildirim, Cemal Beş
Palpable purpura: is it associated with vasculitis or not? A single-center experience. Clinical rheumatology 41 (5) (2022)
Ali Mert, Haluk Vahaboğlu, Ferhat Arslan, Ayşe Batirel, Kemal Tolga Saracoğlu, Aliye Bastug, Arif Atahan Çağatay, Ilim Irmak, Gülçin Telli Dizman, İhsan Ertenli, Lütfiye Nilsun Altunal, Buket Ertürk Sengel, Mehmet Bayram, Ahmet Omma, Shirkhan Amikishiyev, Adalet Aypak, Cemal Bes, Sibel Bolukcu, Sacit Içten, Arzu Topeli, Murat Bektaş, Birsen Yiğit Arslan, Sinan Öztürk, Şenol Çomoğlu, Selda Aydın, Orhan Küçükşahin, Ozan Cemal Icacan, Burak Ince, Sarvan Aghamuradov, Melek Yalçin Mutlu, Funda Şimşek, Salih Emre, Cemal Ustun, Pinar Ergen, Özlem Aydin, Meliha Meriç Koç, Ömür Gökmen Sevindik, Zekaver Odabaşı, Volkan Korten, Hurrem Bodur, Rahmet Güner, Serhat Ünal, Mehmet Kocak, Ahmet Gül
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls. Rheumatology international (2021)
Sinem Girgin, Seda Yurumez, Ahmet Omma, Selda Çelik, Ozan Cemal Icacan, Cemal Beş, Nilufer Alpay-Kanitez
Comparison of relapse rates in Behçet's disease with venous involvement on different doses of azathioprine therapy, a retrospective observational study. International journal of rheumatic diseases 24 (4) (2021)